Weighing up the potential benefits and harms of the Astra-Zeneca COVID-19 vaccine For 100,000 people with high exposure risk. Credit: University of Cambridge - Winton Centre for Risk and Evidence Communication

Communicating the potential benefits and harms of the Astra-Zeneca COVID-19 vaccine

October 29, 2021/in Infographics, Reports and Studies University of Cambridge Global, United Kingdom English Risk Communication and Messaging, Vaccines Researchers, SBC Professionals/by Shane Harper

This powerpoint presentation explains the potential benefits and harms of the Astra-Zeneca COVID-19 vaccine. It contains several graphs to display the potential benefits and harms of people by age and risk; they clearly show that despite the potential risks of the vaccine, complications from COVID-19 are far worse.

Source: Communicating the potential benefits and harms of the Astra-Zeneca COVID-19 vaccine

Johns Hopkins Center for Communication Programs

This website is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the Breakthrough ACTION Cooperative Agreement #AID-OAA-A-17-00017. Breakthrough ACTION is based at Johns Hopkins Center for Communication Programs (CCP).The contents of this website are the sole responsibility of Breakthrough ACTION and do not necessarily reflect the views of USAID, the United States Government, or Johns Hopkins University.

STAY UPDATED